FDA suspends NeoRx's Phase III STR studies

The FDA suspended accrual and treatment in NERX's trials of its Skeletal Targeted Radiotherapy (STR) radiolabeled bone-targeting small molecule, including a Phase III study to treat multiple myeloma, ...